undamentalytics Newsletter

O'toole David D: insider trades

Chief financial officer at 2 companies we cover. 14 open-market purchases and no sales not made under a pre-set plan, reported from September 14, 2012 to February 23, 2026.

Would copying O'toole David D’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 10 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on June 22, 2023 into $8,162 by November 2, 2026, −5.9% a year. The copy held shares only 100% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $18,093, +19.4% a year (the S&P 500 held throughout made $18,033, +19.3% a year). Beta against the index was 1.52. Twelve months after each report, the average purchase was −54.9% against the S&P 500 (median −65.5%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −55.3%.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$10.0k$20.0k 2023202420252026 $18.1k$18.0k$8.2k
Copying O'toole David DS&P 500, same days investedS&P 500, held throughout $10,000 copying O'toole David D’s open-market purchases from June 22, 2023, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−5.9%
S&P 500, same days invested
+19.4% (held throughout +19.3%)
Time in shares
100%
Sharpe ratio (S&P 500)
0.30 (0.95)
Biggest drop (S&P 500)
−84% (−19%)
Market sensitivity (beta)
1.52
Purchases copied
11

Trade by trade

O'toole David D: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 11 −5.5% −21.9% 36% 4 −1.98 0.14 No reliable evidence
Purchases, 6 months after the report 11 −30.5% −52.4% 9% 4 −0.50 0.65 No reliable evidence
Purchases, 12 months after the report 10 −54.9% −65.5% 0% 3 — — Not enough years
Purchases, 12 months after the trade 10 −55.3% −66.0% 0% 3 — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Avita Medical, Inc. RCEL CFO110June 21, 2023February 23, 2026
Codexis, Inc. CDXS SVP & Chief Financial Officer30September 14, 2012March 5, 2013

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 23, 2026February 19, 2026 RCEL Purchase $12,450 −30.6%not yetnot yet
February 19, 2025February 19, 2025 RCEL Purchase $10,250 −30.3%−64.4%−66.9%
December 5, 2024December 5, 2024 RCEL Purchase $12,152 −23.6%−87.7%−85.6%
February 28, 2024February 28, 2024 RCEL Purchase $21,738 −51.9%−66.7%−65.0%
December 12, 2023December 12, 2023 RCEL Purchase $11,828 +16.1%−37.1%−27.6%
November 21, 2023November 21, 2023 RCEL Purchase $20,560 +62.6%−5.6%−6.2%
November 16, 2023November 15, 2023 RCEL Purchase $24,600 +27.4%−29.9%−39.5%
November 15, 2023November 14, 2023 RCEL Purchase $26,130 +29.0%−33.6%−40.3%
August 16, 2023August 16, 2023 RCEL Purchase $34,110 −23.7%−74.0%−73.4%
August 15, 2023August 15, 2023 RCEL Purchase $89,640 −21.9%−73.4%−73.8%
June 21, 2023June 20, 2023 RCEL Purchase $16,150 −13.2%−76.1%−74.9%
March 5, 2013March 4, 2013 CDXS Purchase $20,200 not yetnot yetnot yet
November 14, 2012November 12, 2012 CDXS Purchase $11,000 not yetnot yetnot yet
September 14, 2012September 13, 2012 CDXS Purchase $13,875 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why O'toole David D traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.